IMAGINOSTICS, INC
Medford, MA · CIK 0002122464 · Medtech · Private
Quantitative Ultra-short Time-to-Echo Contrast-Enhanced (QUTE-CE) MRI biomarkers for early detection of vascular pathology in Alzheimer's disease and related dementias
imaginostics.com →- Grants
- $2.3M
- 3 awards
- Sector median: 1
- Raised
- $7.6M
- 7 Form D · May 2026
- 4 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of a Frontier Magnetic Resonance (MR) Imaging Technology As a Tool for Visualization and Quantified Vascular-Feature Measurement for Use in Brain and Behavioral Research on Small Animals | $436,556 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Validation of a Novel Magnetic Resonance Imaging (MRI) Technology for both Diagnostic Screening and Quantification of Brain Vascular Physiology in Alzheimer's-Disease-Related Dementias | $915,931 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Validation of a Novel Magnetic Resonance Imaging (MRI) Technology for both Diagnostic Screening and Quantification of Brain Vascular Physiology in Alzheimer's-Disease-Related Dementias | $915,931 | |
| Private capital raised· 1 of 3 same day | Form D · SEC | $400,000 | |
| Private capital raised· 2 of 3 same day | Form D · SEC | $516,900 | |
| Private capital raised· 3 of 3 same day | Form D · SEC | $100,000 | |
| Private capital raised· 1 of 3 same day | Form D · SEC | $500,000 | |
| Private capital raised· 2 of 3 same day | Form D · SEC | $5,353,594 | |
| Private capital raised· 3 of 3 same day | Form D · SEC | $725,274 | |
| Private capital raised | Form D · SEC | $40,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1331 | ELITE NEURO INC | — | — |
| 1332 | Nido Surgical, Inc | — | $1.3M |
| 1333 | NutriBand Inc. | — | $1.2M |
| 1334 | IMAGINOSTICS, INC | — | $7.6M |
| 1335 | Precipio Diagnostics, LLC | — | $1.1M |
| 1336 | Medical Ingenuities, LLC | — | $997K |
| 1337 | T33 DENTAL, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Valerie GharagouzlooDirector · Executive Officer · Promoter
- Codi GharagouzlooDirector · Executive Officer · Promoter
- VALERIE GHARAGOUZLOODirector · Executive Officer · Promoter
- CODI GHARAGOUZLOODirector · Executive Officer · Promoter
- Scott HogeExecutive Officer
- WILLIAM HOGEExecutive Officer
- Scott ScHogeExecutive Officer
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.